Kodiak Sciences, a clinical-stage biopharmaceutical company specializing in novel ophthalmic therapies, and Lonza announced today that the companies have signed a long-term contract for manufacturing KSI-301, an Antibody Biopolymer Conjugate (ABC) that is a potential first-line treatment for retinal vascular diseases.
Pilot Chemical Company named Frank D. Nataro as the company’s new North America Sales Manager. Nataro will oversee all sales activities of the North American sales team and will be responsible for developing and executing sales strategy that delivers results in line with Pilot’s growth objectives.
Lonza today reported strong Group sales growth of 7.7%3 and a resilient CORE EBITDA margin of 29.1%. The results reflect Lonza Group’s robustness to the challenges and uncertainties arising from the COVID-19 pandemic in H1.
The Society of Chemical Manufacturers & Affiliates (SOCMA) today welcomes the passage of legislation that includes a 3-year reauthorization of the Department of Homeland Security’s (DHS) Chemical Facilities Anti-Terrorism Standards (CFATS).
The Society of Chemical Manufacturers & Affiliates (SOCMA) today released the findings of its inaugural industry census, which indicates specialty chemical companies remain bullish despite the uncertain landscape.
The federal agencies have released their Spring 2020 Regulatory Agendas, which contain agency-by-agency priorities and timelines for upcoming regulatory actions. SOCMA has reviewed the agendas and summarizes upcoming policy activities relevant to SOCMA members.
Monument Chemical, a global producer of specialty chemicals, announced today that Paul Raymond has been named Chief Executive Officer (CEO).
Sun Chemical and its parent company, DIC Corporation, have completed the purchase of 100 percent of the shares of Sensient Imaging Technologies and certain other assets related to the production of inks.
Pilot Chemical announced today the launch of Calfoam® ES-701 10 MAX and Calfoam® ES-702 10 MAX — drop-in solutions designed to help formulators stay in compliance with new 1,4-Dioxane end use product regulations.
Jack Bostock has accepted the position as Chief Commercial Officer, leading the Chemvalon business which is part of the InChem Group, of Rock Hill, S.C. Bostock will also become part of the InChem operating committee.